MedPath

A Randomized Controlled Trial Comparing Clinical Effectiveness of SMILE Versus SMILE Xtra in Myopia

Not Applicable
Recruiting
Conditions
Myopia
Registration Number
NCT06992011
Lead Sponsor
Shanghai Zhongshan Hospital
Brief Summary

To evaluate and compare the clinical efficacy, biomechanical stability, and optical quality of SMILE and SMILE Xtra procedures in patients with myopia through a randomized controlled trial

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
300
Inclusion Criteria
  1. Age 18-50 years
  2. MRSE (Manifest Refraction Spherical Equivalent) -6.00D to -10.00D with refractive changes within ±0.50D in past 2 years
  3. CDVA (Corrected Distance Visual Acuity) ≥ 20/25
  4. Myopia progression ≤ 0.50D/year for ≥2 years
  5. RST (Residual Stromal Thickness) ≥ 250μm after lenticule removal
  6. Contact lens discontinuation as per protocol
Exclusion Criteria
  1. Other eye diseases (keratoconus, glaucoma, etc.)
  2. Corneal scarring, cataracts affecting observation
  3. Systemic diseases affecting surgery compliance
  4. Prior ocular surgeries
  5. Pregnancy, breastfeeding, or menstruation
  6. Drug allergies to surgical medication

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
visual acuity1 week, 1 month,3 months, 6 months, 12 months, 24 months, and 36 months
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Zhongshan Hospital

🇨🇳

Shanghai, Shanghai, China

Zhongshan Hospital
🇨🇳Shanghai, Shanghai, China
Cong Jing
Contact
17269769976
lucky_congjing@163.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.